Arca
Skip to content
Tools
Tools

Alinia (nitazoxanide)

Recall D-0983-2015, part of FDA recall event 70914. See Romark Laboratories's company page.

Romark Laboratories, L.C. started this Class II drug recall on Apr 24, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Oct 25, 2016.

  • Classification: Class II
  • Started: Apr 24, 2015
  • Status: Terminated

Why It Was Recalled

Class II

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Record

Product
Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607
Quantity
32,893 bottles
Lots and codes
Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.
Distribution
Nationwide
Recalling firm
Romark Laboratories, L.C., Tampa, FL, United States
How the firm notified
Letter
FDA classified
May 4, 2015

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.